📑Hepatitis C Praparat - Sofosbuvir und Velpatasvir
Procurement process summary
This process is to purchase Hepatitis C Praparat - Sofosbuvir und Velpatasvir.
This contract was awarded by 🇦🇹 Bundesministerium für Justiz for an amount of EUR 1,459,620 to 1 supplier. It was published on 2019-01-29 through selective
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇦🇹 Bundesministerium für Justiz Buying unitnot reported Publication date2019-01-29 Contest statusnot reported DescriptionGegenstand dieser Rahmenvereinbarung ist die verpflichtende Lieferung von Praparaten mit den Wirkstoffen Sofosbuvir und Velpatasvir zur Hepatitis C Therapie.Awards
This award was granted to Gilead Sciences GesmbH by Bundesministerium für Justiz for an amount of EUR 1,459,620. The procurement process was conducted through selective for the category of goods. This is award number 1.
| Supplier | Amount | Award number |
|---|---|---|
| 🇦🇹 Gilead Sciences GesmbH | EUR 1,459,620 | 1 |
Market context and opportunities
The execution of this contract allows the entity Bundesministerium für Justiz to fulfill its public service objectives efficiently.
The selective purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberAT_ocds-70d2nz-5b912bc7-b5df-44b5-8592-365883e0a4f7-award-1Publication date2019-01-29Contract datenot reportedAward datenot reportedCategoriesgoodsPurchase modalityselectiveMethod detailspt_competitive_negotiationStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
